Cetuximab in squamous cell carcinoma of the head and neck

Author： Hitt Ricardo   Martín Patricia   Hidalgo Manuel  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.2, Iss.4, 2006-08, pp. : 449-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice

By Wang Yixiang  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 237-243

Springer Publishing Company

Access to resources Recommend Favorite

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1247-1253

Spandidos Publications

Access to resources Recommend Favorite

Gene profiling in squamous cell carcinoma of the head and neck

By Akervall Jan  

Cancer and Metastasis Reviews, Vol. 24, Iss. 1, 2005-01 ,pp. : 87-94

Springer Publishing Company

Access to resources Recommend Favorite

Unknown Primary Squamous Cell Carcinoma of the Head and Neck

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite

Retinoic Acid Concentrations in Patients With Squamous Cell Carcinoma of the Head and Neck

By Wahlberg P.   Fex G.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 366-367

Elsevier

Access to resources Recommend Favorite